// company-profile
Liminatus Pharma, Inc. Insider Trading
LIMNEvery SEC Form 4 insider trading filing for Liminatus Pharma, Inc. (LIMN) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
// activity-summary
Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).
// 90-day insight
Over the last 90 days, Liminatus Pharma, Inc. insiders filed 1 Form 4 transaction, none of which were open-market purchases or sales.
- Most active insider: Valetudo Therapeutics LLC with 1 transaction totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Liminatus Pharma, Inc. as of 2026-03-31
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Valetudo Therapeutics LLC | LIMN | J | 4,373,603 | — | — |